| Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272) |
|---|
| 09/19/2006 | US7109339 Substituted tricyclic gamma-carbolines as serotonin receptor agonists and antagonists |
| 09/19/2006 | US7109331 Antiprotozoa agents; 4-pyrrolidine pyrrolo(3,2-d)pyrimidine and 4-pyrrolidine pyrazolo(4,3-d)pyrimidine derivatives |
| 09/19/2006 | US7109229 Methods and compounds for treating proliferative diseases |
| 09/19/2006 | US7109205 Pyrimidine or 1,3,-triazine derivatives; endothelin receptor antagonists |
| 09/19/2006 | US7109199 5-(2,3-Difluorophenyl)-1H-pyrazolo(3,4-c)pyridazin-3-ylamine, e.g.; an enzyme inhibitor of GSK-3, a serine/threonine protein kinase; neuroprotectants in treatment of acute stroke, neurotraumatic injuries and diabetic conditions |
| 09/19/2006 | US7109194 3-heteroaryl-3, 5-dihydro-4-oxo-4H-pyridazino[4, 5-b]indole-1-carboxamide derivatives their preparations and therapeutic use |
| 09/19/2006 | US7109193 Tricyclic diazepines tocolytic oxytocin receptor antagonists |
| 09/19/2006 | US7109192 dipeptidylpeptidase-IV inhibitors; treatment of diabetes and obesity |
| 09/19/2006 | US7109189 Mitochondrially targeted antioxidants |
| 09/19/2006 | US7108847 Delivery of muscle relaxants through an inhalation route |
| 09/19/2006 | CA2232195C Isoxazolidine derivatives |
| 09/14/2006 | WO2006096270A1 Pyrrolopyrimidines useful as inhibitors of protein kinase |
| 09/14/2006 | WO2006095708A1 Porphyrin compound and use thereof |
| 09/14/2006 | WO2006095568A1 Process for oxidation of organic compounds |
| 09/14/2006 | WO2006094948A1 Diaza-spiro-[4.4]-nonane derivatives as neurokinin (nk1) antagonists |
| 09/14/2006 | WO2006094843A1 Piperazine derivatives as glyt1 inhibitors |
| 09/14/2006 | WO2006094672A1 Method of reducing alpha, beta unsaturated ketones in opioid compositions |
| 09/14/2006 | WO2006086464A3 Dihydroquinazolinones as 5ht modulators |
| 09/14/2006 | WO2005037257A3 Novel alanyl-amino peptidase inhibitors for functionally influencing different cells and treating immunological, inflammatory, neuronal, and other diseases |
| 09/14/2006 | US20060205948 such as 2-(2-chloro-phenyl)-5-isopropyl-3-(3,4,5-trifluoro-phenyl)-4,5-dihydro-2H-pyrrolo[3,4-c]pyrazol-6-one; for treatment of eating disorders and psychological disorders |
| 09/14/2006 | US20060205750 Cardiovascular disorders; central nervous system disorders; metabolic diseases; therapy for eating disorders; trans-2-(2-fluorophenyl)-8-[3'-oxospiro[cyclohexane-1,1'(3'H)-isobenzofuran]-4-yl]purine |
| 09/14/2006 | US20060205743 Protein kinase inhibitors |
| 09/14/2006 | US20060205742 Heterocyclic compounds and cerebral function improvers containing the same as the active ingredient |
| 09/14/2006 | US20060205721 3-(Phenyl),5-(3-carmoylphenyl)-amino)-3H-V-triazolo(4,5-D)pyrimidine; bipolar disorder, antidepressants; antidiabetic agents; Alzheimer's disease; blood disorders; dementia; parkinson's disease; neurodegenerative diseases; genetic disorders; muscular disorders; antiinflammatory/anticarcinogenic agents |
| 09/14/2006 | US20060205720 such as 2-(4-chloro-phenyl)-5-cyclopentyl-1-(2-fluoro-phenyl)-5,6-dihydro-1H-pyrrolo[3,4-d]imidazol-4-one; for treatment of eating disorders and psychological disorders |
| 09/14/2006 | US20060205717 For combating phytopathogenic diseases on plants and harvested food crops; pyrido(2,3-B)pyrazine and pyrido pyridazine derivatives; volatile enough to be active in the vapour phase |
| 09/14/2006 | US20060205686 Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase |
| 09/14/2006 | US20060205638 Process for preparing macrocyclic compounds |
| 09/14/2006 | US20060204437 Chlorin and bacteriochlorin-based difunctional aminophenyl DTPA and N2S2 conjugates for MR contrast media and radiopharmaceuticals |
| 09/14/2006 | US20060204436 Tritiated growth hormone secretagogue mk-0677 |
| 09/14/2006 | US20060201862 Cucurbituril-containing polymer, stationary phase and column using the same |
| 09/14/2006 | US20060201385 Containing copper phthalocyanines substituted with both sulfonate and sulfonamide groups (sodium, lithium, ammonia and/or volatile amine salts; nonfading; ozone resistant |
| 09/14/2006 | US20060201384 Copper or nickel phthalocyanine derivative with sulfonate and/or sulfonamide substituents; storage stability, colorfastness |
| 09/14/2006 | CA2599186A1 Diaza-spiro-[4.4]-nonane derivatives as neurokinin (nk1) antagonists |
| 09/14/2006 | CA2597120A1 Methods for oxidizing organic compounds |
| 09/14/2006 | CA2596830A1 Pyrrolopyrimidines useful as inhibitors of protein kinase |
| 09/13/2006 | EP1700859A2 Method for the manufacture of anagrelide |
| 09/13/2006 | EP1700850A1 Novel phenylalanine derivative |
| 09/13/2006 | EP1700843A2 Method for the Manufacture of Anagrelide |
| 09/13/2006 | EP1700842A2 Method for the Manufacture of Anagrelide |
| 09/13/2006 | EP1700841A2 Method for the Manufacture of Anagrelide |
| 09/13/2006 | EP1700840A2 Method for the Manufacture of Anagrelide |
| 09/13/2006 | EP1699844A1 Hyperbranched polymers |
| 09/13/2006 | EP1699802A1 Nicotinic acetylcholine receptor ligands |
| 09/13/2006 | EP1699801A1 Nicotinic acetylcholine receptor ligands |
| 09/13/2006 | EP1699800A2 Bicyclic heterocyclic p-38 kinase inhibitors |
| 09/13/2006 | EP1699799A1 Control of parasites in animals by the use of imidazo [1,2-b]pyridazine derivatives |
| 09/13/2006 | EP1699798A2 Di-substituted pyrrolotriazine compounds |
| 09/13/2006 | EP1699797A1 Pyrrolotriazine compounds as kinase inhibitors |
| 09/13/2006 | EP1699796A1 Azabicyclic heterocycles as cannabinoid receptor modulators |
| 09/13/2006 | EP1699795A1 Substituted 8'-pyri(mi)dinyl-dihydrospiro-[cycloalklymine]-pyrimido[1,2a]pyrimidin-6-one derivatives |
| 09/13/2006 | EP1699794A1 Process for the preparation of triazolopyrimidines |
| 09/13/2006 | EP1699781A1 1-acetic acid-indole, -indazole and -benzimidazole derivatives useful for the treatment of respiratory disorders |
| 09/13/2006 | EP1699767A2 Process for the preparation of pyridopyrimidones |
| 09/13/2006 | EP1699421A2 Pharmaceutically acceptable salts of quinolinone compounds having improved pharmaceutical properties |
| 09/13/2006 | EP1585747B1 5-alkyl-7-aminotriazolopyrimidines, methods and intermediates suitable for their production, agents containing them and their use for controlling harmful fungi |
| 09/13/2006 | EP1483257B1 Quinazoline compounds useful in therapy |
| 09/13/2006 | EP1412364B1 Platelet adp receptor inhibitors |
| 09/13/2006 | EP1392684B1 Thiazole compounds useful as inhibitors of protein kinases |
| 09/13/2006 | EP1335918B1 Novel compounds |
| 09/13/2006 | EP1296997B1 Base analogues |
| 09/13/2006 | EP1237888B1 Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists |
| 09/13/2006 | EP1082155B1 Dry powder dispersing apparatus and methods for their use |
| 09/13/2006 | CN1832949A Phosphoric acid salt of a dipeptidyl peptidase-iv inhibitor |
| 09/13/2006 | CN1832938A N-heterocyclyl phenyl-substituted cyclic ketoenols |
| 09/13/2006 | CN1832925A New p2x7 receptor avtagonists and their use |
| 09/13/2006 | CN1830979A Quinazolin allkaloids compound, prepn. method and use thereof |
| 09/13/2006 | CN1274692C Total synthesizing meethod for pyrrole heterocyclic alkaloid aldisin |
| 09/13/2006 | CN1274691C Two new compounds for treating impotence |
| 09/13/2006 | CN1274690C Tricyclic and heterocyclic derivative compounds and drugs containing these compounds as active ingredient |
| 09/13/2006 | CN1274670C Diaminopropionic acid derivatives |
| 09/12/2006 | US7105667 Fused heterocyclic compounds and use thereof |
| 09/12/2006 | US7105664 5-Halogen-6-phenyl-7-fluoroalkylamino-triazolopyrimidines as fungicides |
| 09/12/2006 | US7105663 Derivatives of pyrimido[6,1-a]isoquinolin-4-one |
| 09/12/2006 | US7105660 Intramolecular amidation of sulfamates catalyzed by metalloporphyrins |
| 09/12/2006 | US7105550 2,4-disubstituted thiazolyl derivatives |
| 09/12/2006 | US7105533 3-(3-methoxy-4-(pyridin-2-yl)phenyl)imidazo[1,5-a]pyridine hydrochloride; mGluR5 modulators treating psychiatric and mood disorders, schizophrenia, anxiety, depression, panic, pain |
| 09/12/2006 | US7105529 A novel compound for treating alopecia induced by cancer chemotherapy or radiotherapy |
| 09/12/2006 | US7105526 Benzimidazole derivatives |
| 09/12/2006 | US7105509 Benzodiazepine derivatives as APP modulators |
| 09/12/2006 | US7105507 Cyclohexane derivatives and their use as therapeutic agents |
| 09/12/2006 | US7105506 For therapy of cardiovascular disorders and erectile dysfunction |
| 09/12/2006 | US7105471 Arylphenyl-substituted cyclic ketoenols |
| 09/10/2006 | CA2500558A1 A process for the preparation of aza-containing bicyclic compounds and the use thereof in the preparation of cilazapril |
| 09/08/2006 | WO2006094248A1 Aryl-substituted cyclic sirtuin modulators |
| 09/08/2006 | WO2006093987A1 Tricyclic-nucleoside compounds for treating viral infections |
| 09/08/2006 | WO2006093986A1 Tricyclic-nucleoside prodrugs for treating viral infections |
| 09/08/2006 | WO2006093269A1 Optically active ammonium salt compound, production intermediate thereof and method for producing same |
| 09/08/2006 | WO2006092428A2 2-substituted 7-amino-azolopyrimidine, a method for the production and use thereof for controlling pathogenic fungi and agents containing said compound |
| 09/08/2006 | WO2006092414A1 5,6-dialkyl-7-amino-azolopyrimidines, method for their production, their use for controlling pathogenic fungi and agents containing said compounds |
| 09/08/2006 | WO2006092413A1 5,6-dialkyl-7-amino-azolopyrimidines, method for their production, their use for controlling pathogenic fungi and agents containing said compounds |
| 09/08/2006 | WO2006092412A1 5,6-dialkyl-7-amino-azolopyrimidines, method for their production, their use for controlling pathogenic fungi and agents containing said compounds |
| 09/08/2006 | WO2006092411A1 5,6-dialkyl-7-amino-azolopyrimidines, methods for the production thereof, use thereof for controlling harmful fungi, and substances containing the same |
| 09/08/2006 | WO2006073610A8 Novel bicyclic heterocyclic compounds, process for their preparation and compositions containing them |
| 09/08/2006 | WO2006063841A3 Trycyclic heterocycles, their manufacture and use as pharmaceutical agents |
| 09/08/2006 | WO2006023889A3 A method for preparing irbesartan and intermediates thereof |
| 09/08/2006 | CA2597685A1 Tricyclic-nucleoside compounds for treating viral infections |
| 09/08/2006 | CA2597683A1 Tricyclic-nucleoside prodrugs for treating viral infections |
| 09/07/2006 | US20060199882 Heterocyclic dyes based on benzodipyrroles |
| 09/07/2006 | US20060199826 Cyclopropane compounds and pharmaceutical use thereof |